Literature DB >> 16525682

Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.

Hideo Shigeishi1, Shingo Yoneda, Masayuki Taki, Takeshi Nobumori, Kouji Ohta, Koichiro Higashikawa, Wataru Yasui, Nobuyuki Kamata.   

Abstract

Human Bub1 plays an important role at the spindle assembly check-point to prevent cell cycle progression following spindle damage. We examined the expression of Bub1 mRNA and protein in 21 human salivary gland tumors (7 pleomorphic adenomas, 2 warthin tumors, 5 mucoepidermoid carcinomas, 3 adenoid cystic carcinomas and 4 acinic cell carcinomas) and 3 normal submandibular glands using real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) or western blotting. The mean expression levels of Bub1 mRNA and protein were higher in malignant tumors (0.12+/-0.028/1.75+/-0.53) than normal submandibular glands (0.042+/-0.014/0.19+/-0.044) and benign tumors (0.058+/-0.01/0.97+/-0.44). We found a significant association between the level of Bub1 mRNA/protein expression and clinical stage in malignant tumors (Mann-Whitney U test, p=0.019/p=0.016). We analyzed its relation with the proliferative activity monitored by the Ki-67 labeling index by immunohistochemistry as well as the expression of proliferating cell nuclear antigen (PCNA) by Western blotting. A significant correlation was found between Bub1 mRNA/protein expression and the Ki-67 labeling index in salivary gland tumors (Spearman's correlation coefficient by rank test, p=0.026/p=0.002). These results indicate that increased expression of the human Bub1 gene is closely linked to abnormal cell proliferation in malignant conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525682

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Clinicopathological analysis of salivary gland carcinomas and literature review.

Authors:  Hideo Shigeishi; Kouji Ohta; Gaku Okui; Sayaka Seino; Miho Hashikata; Kazuhiro Yamamoto; Yoko Ishida; Kazuki Sasaki; Takako Naruse; Mohammad Zeshaan Rahman; Ryo Uetsuki; Akiko Nimiya; Shigehiro Ono; Hiroshi Shimasue; Koichiro Higashikawa; Masaru Sugiyama; Masaaki Takechi
Journal:  Mol Clin Oncol       Date:  2014-10-09

2.  BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients.

Authors:  Kiyoshi Takagi; Yasuhiro Miki; Yukiko Shibahara; Yasuhiro Nakamura; Akiko Ebata; Mika Watanabe; Takanori Ishida; Hironobu Sasano; Takashi Suzuki
Journal:  Horm Cancer       Date:  2013-01-04       Impact factor: 3.869

3.  Novel molecular markers of malignancy in histologically normal and benign breast.

Authors:  Aejaz Nasir; Dung-Tsa Chen; Mike Gruidl; Evita B Henderson-Jackson; Chinnambally Venkataramu; Susan M McCarthy; Heyoung L McBride; Eleanor Harris; Nazanin Khakpour; Timothy J Yeatman
Journal:  Patholog Res Int       Date:  2011-07-10

Review 4.  A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation.

Authors:  Pawel Sowa; Karolina Goroszkiewicz; Joanna Szydelko; Joanna Chechlinska; Katarzyna Pluta; Wojciech Domka; Maciej Misiolek; Wojciech Scierski
Journal:  Biomed Res Int       Date:  2018-08-01       Impact factor: 3.411

5.  Bub1 is required for maintaining cancer stem cells in breast cancer cell lines.

Authors:  Jeong Yoon Han; Yu Kyeong Han; Ga-Young Park; Sung Dae Kim; Chang Geun Lee
Journal:  Sci Rep       Date:  2015-11-02       Impact factor: 4.379

6.  Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis.

Authors:  Shuyu Liu; Xinkui Liu; Jiarui Wu; Wei Zhou; Mengwei Ni; Ziqi Meng; Shanshan Jia; Jingyuan Zhang; Siyu Guo; Shan Lu; Yingfei Li
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.